Department of Haematology and Haematological Stem Cell Transplantation, St Vincent's Hospital, Sydney, New South Wales, Australia.
Thromb Haemost. 2010 May;103(5):1044-52. doi: 10.1160/TH09-09-0644. Epub 2010 Apr 13.
It has been widely accepted that microparticles expose phosphatidylserine which in turn binds annexin V. It was the objective of this study to compare the antigenic characteristics and phospholipid-dependent procoagulant activity of annexin V positive and -negative subpopulations of platelet-derived microparticles. Annexin V positive and -negative microparticles were identified and characterised using flow cytometry and procoagulant activity was measured by a phospholipid-dependent assay (XACT). In unstimulated platelet-poor plasma, 80% of platelet-derived microparticles failed to bind annexin V. Varying the assay constituents (buffer, calcium and annexin V concentration) did not alter annexin V binding. The proportion of microparticles that bound annexin V was dependent upon the agonist, with physiological agonists such as collagen resulting in fewer annexin V binding microparticles than non-physiological agonists such as ionophore. CD42b (glycoprotein Ib) expression was significantly decreased and CD62p and CD63 expression were significantly increased in annexin V positive compared to annexin V negative subpopulations. There was no significant difference in CD41, CD61, CD42a and CD40L expression between annexin V positive and -negative subpopulations. A significant correlation between annexin V binding and XACT was found (p=0.033). Annexin V inhibited greater than 95% of phospholipid activity, suggesting that annexin V binding was a true reflection of procoagulant activity. The majority of platelet-derived microparticles in unstimulated plasma failed to bind annexin V and showed significantly increased levels of CD42b compared to annexin V positive events. Phospholipid-dependent procoagulant activity is limited to the annexin V positive subpopulation and is agonist-dependent. The significance of annexin V negative microparticles is unclear, however, it is possible that they possess other activities aside from procoagulant phospholipid activity.
已广泛接受的观点是,微粒体暴露磷脂酰丝氨酸,继而与 annexin V 结合。本研究旨在比较 annexin V 阳性和阴性血小板衍生微粒体亚群的抗原特征和依赖磷脂的促凝活性。使用流式细胞术鉴定 annexin V 阳性和阴性微粒体,并通过依赖磷脂的测定法(XACT)测定促凝活性。在未刺激的血小板少血浆中,80%的血小板衍生微粒体未能与 annexin V 结合。改变测定成分(缓冲液、钙和 annexin V 浓度)不会改变 annexin V 结合。与 annexin V 结合的微粒体比例取决于激动剂,生理激动剂如胶原导致与非生理激动剂如离子载体相比,结合 annexin V 的微粒体更少。与 annexin V 阴性亚群相比,annexin V 阳性亚群的 CD42b(糖蛋白 Ib)表达显著降低,CD62p 和 CD63 表达显著增加。annexin V 阳性和阴性亚群之间 CD41、CD61、CD42a 和 CD40L 的表达无显著差异。annexin V 结合与 XACT 之间存在显著相关性(p=0.033)。annexin V 抑制了超过 95%的磷脂活性,表明 annexin V 结合是促凝活性的真实反映。在未刺激的血浆中,大多数血小板衍生微粒体未能与 annexin V 结合,与 annexin V 阳性事件相比,CD42b 的水平显著增加。依赖磷脂的促凝活性仅限于 annexin V 阳性亚群,且依赖激动剂。annexin V 阴性微粒体的意义尚不清楚,但是,它们除了具有促凝磷脂活性之外,还可能具有其他活性。